Corvia Medical is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Founded in 2009 and headquartered in Tewksbury, MA, Corvia is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia Atrial Shunt was granted Breakthrough Device designation by the FDA in 2019.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/09/22 | $54,000,000 | Venture | ||
| 06/17/25 | $55,000,000 | Venture |
Accelmed General Catalyst Lumira Ventures Third Rock Ventures | undisclosed |
